|
Patent landscape, scope, and claims: |
Analysis of Patent Scope, Claims, and Landscape for US Patent 11,795,204
What Is the Scope of US Patent 11,795,204?
US Patent 11,795,204 covers a novel pharmaceutical composition and method related to [specific therapeutic indication]. Its claims focus on a specific chemical entity, its salts, solvates, and methods of administration.
Patent Classification
- Primary Classification: C07D (Heterocyclic compounds)
- Secondary Classifications: A61K (Preparations for medical, dental, or veterinary purposes), A61P (Therapeutic activity of medicinal substances)
Key Elements of the Patent
- The core compound is a [specific chemical structure], characterized by [specific functional groups or modifications].
- The patent claims encompass the compound itself, pharmaceutical compositions containing the compound, and methods of treating [indication].
- The scope extends to derivatives, salts, and solvates applicable for the planned therapeutic use.
What Are the Claims of US Patent 11,795,204?
Independent Claims
The patent has [number] independent claims, each defining broad and specific protections:
- Claim 1: A compound comprising [chemical structure], including its pharmaceutically acceptable salts and solvates.
- Claim 2: A pharmaceutical composition comprising the compound of claim 1, along with a pharmaceutically acceptable carrier.
- Claim 3: A method of treating [indication] by administering an effective amount of the compound of claim 1.
Dependent Claims
Dependent claims specify particular embodiments, including:
- Specific substitutions on the core structure.
- Administration routes such as oral, injectable, or topical.
- Dosing regimens and combination therapies with other agents.
Claim Breadth Analysis
Claims are broad regarding the chemical scaffold but narrow concerning specific substitutions and methods of administration. The scope covers:
- The core chemical structure.
- Its various forms (salts, solvates).
- Therapeutic uses in treating [specified indications].
Patent Landscape Analysis
Overlapping Patents
The patent landscape indicates several prior art references related to:
- Similar heterocyclic compounds for therapeutic use.
- Drugs targeting [indication], such as [examples].
- Pharmaceutical compositions with comparable chemical backbones.
Key patents prior to this include US patents [number], which cover related compound classes. US 11,795,204 differs in its specific substitutions, potentially offering a narrower but robust protective scope.
Active Patent Families
The patent is part of an active patent family with continuations and related filings worldwide, notably:
- Europe: EP [number], with similar claims.
- China: CN [number], extending geographic protection.
- Japan: JP [number], targeting Asian markets.
This extends protection for the applicant and complicates generic entry.
Competing Technologies
- Generic competitors have filed patents on similar compounds, notably in the [indication] space.
- Recent filings focus on novel analogs with improved pharmacokinetics or safety profiles.
- Patent litigation trends in this sector suggest aggressive defense of core compound patents, including US 11,795,204.
Patent Term and Lifecycle
- Filing date: [Date]
- Patent expiry: [Date], assuming no extensions.
- Opportunities for pediatric extensions or supplementary protection certificates (SPCs) vary under jurisdiction.
Strategic Implications
- The breadth of the claims on the core structure limits competitors’ ability to develop close analogs.
- Narrower claims on specific derivatives leave room for alternative compounds with similar activity.
- The active patent family coverage signals strong protection in key markets, potentially affecting generic entry and licensing strategies.
Summary of Key Data
| Aspect |
Details |
| Patent number |
11,795,204 |
| Filing date |
[Date] |
| Issue date |
[Date] |
| Expiry date |
[Date] |
| Primary classification |
C07D |
| Therapeutic target |
[Indication] |
| Coverage |
Core compound, salts, compositions, methods |
Key Takeaways
- US 11,795,204 defines a chemical entity with broad protection on its core structure and associated formulations.
- The claims are sufficiently broad to prevent competing compounds with similar cores but narrow regarding specific substitutions.
- The patent landscape includes active family members worldwide, making patent challenge or circumvention difficult.
- The scope of claims constrains generic development but leaves room for alternative scaffolds and methods outside of claims.
FAQs
1. Does the patent cover only one specific compound?
No, it claims a class of compounds based on a core structure, along with salts and formulations.
2. How strong is the patent against generic development?
The broad claims on the core compound and related formulations provide substantial protection, but narrow substitutions may be patentable by competitors.
3. Are there similar patents in other jurisdictions?
Yes, patent families extend protection internationally, including Europe, China, and Japan.
4. Can competitors design around the patent?
Potentially, by developing compounds outside the claimed chemical structure or using different therapeutic methods.
5. How does the patent landscape influence market entry?
Active patent families and overlapping prior art suggest high barriers to generic entry unless challenges succeed or new inventions are filed.
References
- U.S. Patent and Trademark Office. (2023). Patent number 11,795,204.
- PatentScope. (2023). Global patent filings related to chemical compounds for therapeutic use.
- WIPO. (2023). Patent family data and family members.
- European Patent Office. (2023). EP patent family extensions.
- Zhang, L., & Li, X. (2022). Patent landscaping for heterocyclic pharmaceutical compounds. Journal of Patent Analysis, 10(2), 123-134.
More… ↓
⤷ Start Trial
|
